Nobiletin as a Neuroprotectant against NMDA Receptors: An In Silico Approach

Area of Science:

• Neuroscience
• Pharmacology
• Computational Chemistry

Background:

• Excitotoxicity, driven by excessive glutamate receptor activation, causes neuronal damage and is linked to neurodegenerative disorders.
• N-methyl-D-aspartate (NMDA) receptors are key mediators of excitotoxicity due to their role in calcium ion influx.
• Targeting NMDA receptors is a critical strategy for developing treatments for excitotoxicity.

Purpose of the Study:

• To computationally screen five phytochemicals for their potential to inhibit human NMDA receptors.
• To evaluate the drug-like properties and toxicity profiles of these compounds using in silico ADMET studies.
• To identify promising neuroprotectant candidates for further investigation.

Main Methods:

• Utilized molecular docking and molecular dynamics (MD) simulations to assess compound interactions with NMDA receptor binding sites.
• Performed in silico ADMET analysis to predict pharmacokinetic and toxicity profiles.
• Applied multiple drug-likeness rules (Veber, Lipinski, Ghose, Muegge, Egan) and alert checks (PAINS, Brenks).

Main Results:

• Nobiletin demonstrated effective binding to the NMDA receptor's active site with stable dynamics.
• Nobiletin satisfied all tested drug-likeness criteria and showed no structural alerts for toxicity.
• Other screened compounds (silibinin, ononin, ginkgolide B, EGCG) were also evaluated for comparison.

Conclusions:

• Nobiletin exhibits significant potential as a neuroprotectant agent against excitotoxicity.
• Its favorable pharmacokinetic and toxicity profile suggests therapeutic viability.
• Further in vitro and in vivo studies are warranted to validate nobiletin's neuroprotective efficacy.